Background: A recent review identified many prognostic scores used for covid-19, which varied in their setting, predicted outcome measure, and the clinical parameters included. The large number of risk stratification tools reflects difficulties in their application, with most scores showing moderate performance at best and no benefit to clinical decision making.
Areas of work